On the eve of over-the-counter birth control pills, the GOP can’t possibly convince Americans that the right to contraception is wrong.
FDA
Big Tobacco Outmaneuvers the FDA on Flavored Nicotine Products
On menthol and disposable vapes, public-health activists say the regulatory agency is moving way too slow.
How Progressives Went to Pot
In libertarian America, causes like legalizing weed are the easy part. Reforms to constrain capitalism or enlarge social solidarity are far harder—and far more essential.
The Next Insulin Scandal
A generic cold medicine available in Europe also turns out to have benefits for Parkinson’s. Biden could prevent the usual effort to patent it and jack up the price.
How Do You Spell Relief?
Today on TAP: After an FDA finding that a popular decongestant is worthless, Biden could direct that agency to fast-track approval of a miracle drug for colds used all over the world.
Pricing a Lifesaving Drug
Will Medicare use its ample leverage to make Wegovy affordable?
The Post-Ozempic Gold Rush
So much energy is going into developing effective weight loss pills, while hundreds of lifesaving medications remain in shortage.
Stirrings of a Conservative Christian Rule of Law
The court case involving the FDA approval of mifepristone revealed a little too much about the conservative movement’s aims.
Drug Shortages as an Indictment of Capitalism
Here is a vital sector of the economy crying out for socialized production and distribution.

